Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  BOLSA DE VALORES DE SAO PAULO  >  Fleury SA    FLRY3   BRFLRYACNOR5


End-of-day quote. End-of-day quote  - 07/26
30.25 BRL   --.--%
07/25 MATERIAL FACT : Stock Option Plan
04/29 FLEURY : Financial Statements - 1Q16
04/08 FLEURY : Notice to the shareholders: dividends
News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

Material Fact: Stock Option Plan

share with twitter share with LinkedIn share with facebook
share via e-mail
07/25/2016 | 11:37pm CEST
e6cfc3bb-473b-4eca-ac94-7a46518168e5.pdf FLEURY S.A. Public Company CNPJ nº 60.840.055/0001-31 NIRE nº 35.300.197.534 Material Fact

Fleury S.A. ("Grupo Fleury" or "Company"), pursuant to article 157 of the Law 6.404/76 and CVM Instruction 358/2002, announces to its shareholders and the market that, in the Extraordinary General Meeting held on July 25th 2016, according to the proposal presented by the management, was approved the stock option plan for the Company's shares ("Stock Option Plan") for its executives, managers and employees.

The main objectives of the Stock Option Plan are as follows: (i) to stimulate the Company's expansion as well as the achievement and overcoming of the established business goals by creating long-term incentives that aim a greater integration of its executives, managers and employees as the Company's shareholders; (ii) to allow the Company to retain its employees, offering them an advantageous and additional incentive, the opportunity to become shareholders of the Company in the terms, conditions and forms established in this Stock Option Plan; and (iii) to promote the good performance of the Company and the interests of its shareholders through a long-term commitment by part of its executives, managers and employees.

The options granted under this Stock Option Plan cannot exceed, during the term of the Stock Option Plan, the cumulative maximum limit of 2.5% (two point five percent) of the total shares of the Company's subscribed and paid capital on the date hereof. The Board of Directors will coordinate this Stock Option Plan.

To access the Stock Option Plan's full version, please visit: www.fleury.com.br/ir.

São Paulo, July 25th 2016.

Adolpho C. Souza Neto Investor Relations Officer

Fleury SA published this content on 25 July 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 25 July 2016 21:36:05 UTC.

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on FLEURY SA
07/25 MATERIAL FACT : Stock Option Plan
04/29 FLEURY : Financial Statements - 1Q16
04/08 FLEURY : Notice to the shareholders: dividends
02/03 FLEURY : Notice to the market: transfer of shares - Integritas
2015 FLEURY : Material fact: change of media outlet
2015 FLEURY : Material Fact: Closing Cruzeiro do Sul
2015 FLEURY : Financial Statements - 3Q15
2015 FLEURY : Notice to the market: independent auditor replacement
2015 FLEURY : Notice to shareholders: Dividend payments
2015 FLEURY : Material Fact: health’s solid waste tax
More news
Sector news : Medical & Diagnostic Laboratories
07/21DJQUEST DIAGNOSTICS : Profit Rises, Helped by Lower Costs
06/28DJNestlé Turns to Health Sector for Next CEO -- WSJ
06/27 FRESENIUS SE KGAA : Nestle poaches CEO from Fresenius in health and wellness dri..
06/27DJNestle Taps Schneider as Next CEO -- Update
06/27DJNestlé Taps Schneider as Next CEO
More sector news : Medical & Diagnostic Laboratories
Financials ( BRL)
Sales 2016 2 099 M
EBIT 2016 306 M
Net income 2016 178 M
Debt 2016 263 M
Yield 2016 0,85%
P/E ratio 2016 26,49
P/E ratio 2017 20,97
EV / Sales 2016 2,38x
EV / Sales 2017 2,09x
Capitalization 4 728 M
More Financials
Duration : Period :
Fleury SA Technical Analysis Chart | FLRY3 | BRFLRYACNOR5 | 4-Traders
Full-screen chart
Technical analysis trends FLEURY SA
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus OUTPERFORM
Number of Analysts 8
Average target price 24,0  BRL
Spread / Average Target -21%
Consensus details
EPS Revisions
More Estimates Revisions
Carlos Alberto Iwata Marinelli Chief Executive Officer
Marcos Bosi Ferraz Chairman
Adolpho Cyriaco Nune de Souza Neto Chief Finance Officer & Head-Investor Relations
Teresa Sacchetta Executive Director-Information Technology
Samuel Monteiro dos Santos Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
FLEURY SA90.83%1 441
HCA HOLDINGS INC17.85%31 167
LABORATORY CORP. OF AM..11.49%14 115
More Results